Antibody Responses in Oral Fluid after Administration of Prophylactic Human Papillomavirus Vaccines
- 1 November 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 200 (9) , 1452-1455
- https://doi.org/10.1086/606026
Abstract
We sought to determine whether oral fluid can be used to assess serum human papillomavirus (HPV) antibody status by enrolling women who had received aKeywords
This publication has 15 references indexed in Scilit:
- Comparison of oral fluid and serum ELISAs in the determination of IgG response to natural human papillomavirus infection in university womenJournal of Clinical Virology, 2006
- Suppression of non-specific binding in serological Luminex assaysJournal of Immunological Methods, 2006
- Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial NeoplasiaObstetrics & Gynecology, 2006
- The use of the OraSure® collection device for hepatitis virus testing in health care settingsJournal of Clinical Virology, 2005
- Multiplex Human Papillomavirus Serology Based on In Situ–Purified Glutathione S-Transferase Fusion ProteinsClinical Chemistry, 2005
- Human Papillomavirus-Specific Antibody Status in Oral Fluids Modestly Reflects Serum Status in Human Immunodeficiency Virus-Positive IndividualsClinical and Vaccine Immunology, 2003
- Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia.2001
- Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia.2001
- Future Applications of Oral Fluid Specimen TechnologyThe American Journal of Medicine, 1997
- A Comparative Study of Saliva and OraSure® Oral FluidAnnals of the New York Academy of Sciences, 1993